Delivery of PTEN represents an exciting potential future cancer therapeutic strategy; proof of concept has been achieved in vivo, whereby PTEN mRNA delivery via nanoparticles resulted in restoration of tumour growth suppression in a murine model [65], and human studies are eagerly awaited. This evidence concerns the gene PTEN and neoplasm.